Posted by Michael Wonder on 12 Aug 2016
CADTH calls for patient input on submission from Janssen for Stelara (ustekinumab)
12 August 2016 - CADTH has received notice of a pending submission from Janssen for ustekinumab for use by patients with Crohn's disease.
Ustekinumab is yet to be approved by Health Canada for such use.
CADTH is expecting the submission from Janssen on 12 September 2016.
